α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra and the formation of aggregates (Lewy bodies) in neurons. alpha-Synuclein is the major protein in Lewy bodies and rare mutations in alpha-synuclein cause early-onset PD. Consequently, alpha-synuclein is implicated in the pathogenesis of PD. Here, we have investigated the degradation pathways of alpha-synuclein, using a stable inducible PC12 cell model, where the expression of exogenous human wild-type, A30P, or A53T alpha-synuclein can be switched on and off. We have used a panel of inhibitors/stimulators of autophagy and proteasome function and followed alpha-synuclein degradation in these cells. We found that not only is alpha-synuclein degraded by the proteasome, but it is also degraded by autophagy. A role for autophagy was further supported by the presence of alpha-synuclein in organelles with the ultrastructural features of autophagic vesicles. Since rapamycin, a stimulator of autophagy, increased clearance of alpha-synuclein, it merits consideration as a potential therapeutic for Parkinsons disease, as it is designed for chronic use in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, mutant forms of synuclein and oligomers are dependent on the autophagy–lysosome pathway for their clearance4–6.”
From Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice (2018) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies suggest that α-synuclein is degraded by macroautophagy, chaperone-mediated autophagy, and the proteasome20–23.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Macroautophagy is a key pathway for the clearance of aggregate-prone cytosolic proteins.”
From Lithium induces autophagy by inhibiting inositol monophosphatase (2005) · cites this paper as Webb et al., 2003
In the citing paper
“Early evidence suggested roles for CMA and macroautophagy in degrading SNCA/α‐synuclein (Webb et al, 2003; Cuervo et al, 2004).”
From Autophagy in major human diseases (2021) · cites this paper as Webb et al, 2003
In the citing paper
“We previously showed that EGFP-HDQ74 is cleared by autophagy.”
From Lithium induces autophagy by inhibiting inositol monophosphatase (2005) · cites this paper as Webb et al., 2003
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Greene, L. A., & Tischler, A. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.7.2424 · Cited by 5,553
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Research works printed but not linked: 2
- Furlong, R. A., Narain, Y., Rankin, J., Wyttenbach, A., and Rubinsztein, D. C. (2000) Biochem. J. 346, 577-581 · DOI · Paper page
- Biederbick, A., Kern, H. F., and Elsasser, H. P. (1995) Eur. J. Cell Biol. 66, 3-14
Cited by
Items 301–400 of 1,001
Beyer, K., & Ariza, A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8330-5 · Cited by 158
“The mechanisms involved in proteolytic AS cleavage are not fully understood, but both proteasomal [87, 89] and lysosomal [63, 90, 91] pathways have been implicated in AS degradation and various other candidate proteases have been proposed to be able to cleave AS.”
BackgroundAutophagy and misfolded proteins in neurodegeneration
Metcalf, D. J., García-Arencibia, M., Hochfeld, W. E., & Rubinsztein, D. C. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2010.11.003 · Cited by 138
“Our studies have established that rapamycin treatment enhances the clearance of mutant huntingtin fragments, reduces aggregate formation and protects against toxicity in cell, Drosophila and mouse models of Huntington's disease (HD) (Berger et al., 2006; Ravikumar et al., 2006; Sarkar et al., 2009;Webb et al., 2003).”
BackgroundSelf-citationAutophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Senkevich, K., & Gan-Or, Z. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.11.015 · Cited by 132
Brady, N. R., Hamacher‐Brady, A., Yuan, H., & Gottlieb, R. A. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05849.x · Cited by 137
Schapansky, J., Khasnavis, S., DeAndrade, M. P., Nardozzi, J. D., Falkson, S. R., Boyd, J. D., Sanderson, J. B., Bartels, T., Melrose, H. L., & LaVoie, M. J. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.12.005 · Cited by 136
Machiya, Y., Hara, S., Arawaka, S., Fukushima, S., Sato, H., Sakamoto, M., Koyama, S., & Kato, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141952 · Cited by 151
Zhuang, X.-X., Wang, S.-F., Tan, Y., Song, J.-X., Zhu, Z., Wang, Z.-Y., Wu, M.-Y., Cai, C.-Z., Huang, Z.-J., Tan, J.-Q., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2322-6 · Cited by 127
Restoration of CTSD (cathepsin D) and lysosomal function in stroke is neuroprotective
Hossain, M. I., Marcus, J. M., Lee, J. H., Garcia, P. L., Singh, V., Shacka, J. J., Zhang, J., Gropen, T. I., Falany, C. N., & Andrabi, S. A. (2020) · Autophagy · doi:10.1080/15548627.2020.1761219 · Cited by 143
“Similarly, the accumulation and aggregation of SNCA (synuclein, alpha) lead to the loss of dopaminergic neurons in PD [10,11].”
BackgroundAntagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy
Kim, C., Rockenstein, E., Spencer, B., Kim, H.-K., Adame, A., Trejo, M., Stafa, K., Lee, H.-J., Lee, S.-J., & Masliah, E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.044 · Cited by 135
“Therefore, inhibition of lysosomal and autophagic functions resulted in the accumulation of a-synuclein aggregates in cells (Lee et al., 2004; Webb et al., 2003).”
Role of molecular chaperones in neurodegenerative disorders
Meriin, A. B., & Sherman, M. Y. (2005) · International Journal of Hyperthermia · doi:10.1080/02656730500041871 · Cited by 134
“In fact, inhibitors of the autophagy caused a dramatic increase of the number of inclusion bodies with polyQ and other abnormal proteins in cell culture [17, 18].”
BackgroundThe complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease
Schapansky, J., Nardozzi, J. D., & LaVoie, M. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.049 · Cited by 132
“Both the ubiquitin-proteosome system (UPS) and the ALP have been implicated (Webb et al., 2003; Cuervo et al., 2004), and again outcomes appear to depend largely on the αSyn conformation being analyzed (for an in depth review see (Xilouri et al., 2013)).”
BackgroundDu, T.-T., Wang, L., Duan, C.-L., Lu, L.-L., Zhang, J.-L., Gao, G., Qiu, X.-B., Wang, X.-M., & Yang, H. (2015) · Autophagy · doi:10.1080/15548627.2015.1086055 · Cited by 129
“In addition to the lysosome, autophagic vacuoles are a compartment required for SNCA clearance.(49) Moreover, gene replacement of BECN1, which stimulates autophagy, abrogates the deleterious effects of SNCA overexpression in animal models Figure 9.”
BackgroundConsensus Paper: Pathological Mechanisms Underlying Neurodegeneration in Spinocerebellar Ataxias
Matilla‐Dueñas, A., Ashizawa, T., Brice, A., Magri, S., McFarland, K. N., Pandolfo, M., Pulst, S. M., Rieß, O., Rubinsztein, D. C., Schmidt, J., et al. (2013) · The Cerebellum · doi:10.1007/s12311-013-0539-y · Cited by 145
Self-citationFelodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing
Siddiqi, F. H., Menzies, F. M., Lopez, A., Stamatakou, E., Karabiyik, C., Ureshino, R., Ricketts, T., Jimenez-Sanchez, M., Esteban, M. A., Lai, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09494-2 · Cited by 128
Self-citationAutophagy deregulation in neurodegenerative diseases – recent advances and future perspectives
Cheung, Z. H., & Ip, N. Y. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07314.x · Cited by 127
Al-Wandi, A., Ninkina, N., Millership, S., Williamson, S. J. M., Jones, P. A., & Buchman, V. L. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.001 · Cited by 129
Autophagy in health and disease: From molecular mechanisms to therapeutic target
Lu, G. X., Wang, Y., Shi, Y. P., Zhang, Z., Huang, C., He, W., Wang, C., & Shen, H. (2022) · MedComm · doi:10.1002/mco2.150 · Cited by 149
α-Synuclein and Neuronal Cell Death
Yasuda, T., Nakata, Y., & Mochizuki, H. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8327-0 · Cited by 129
“agy [78, 79].”
Pathophysiological importance of aggregated damaged proteins
Höhn, A., Jung, T., & Grune, T. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.028 · Cited by 138
Florez-McClure, M. L., Hohsfield, L. A., Fonte, G., Bealor, M. T., & Link, C. D. (2007) · Autophagy · doi:10.4161/auto.4776 · Cited by 124
“Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis.”
BackgroundMethodInfluentialProtein misfolding disorders and macroautophagy
Menzies, F. M., Moreau, K., & Rubinsztein, D. C. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.10.010 · Cited by 129
Self-citationAutophagy in neurodegeneration and development
Winslow, A. R., & Rubinsztein, D. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.06.010 · Cited by 126
Self-citationSNCA (α-synuclein)-induced toxicity in yeast cells is dependent on Sir2-mediated mitophagy
Sampaio-Marques, B., Felgueiras, C., Silva, A., Rodrigues, M., Tenreiro, S., Franssens, V., Reichert, A. S., Outeiro, T. F., Winderickx, J., & Ludovico, P. (2012) · Autophagy · doi:10.4161/auto.21275 · Cited by 123
Molecular Pathology of Lewy Body Diseases
Beyer, K., Domingo-Sàbat, M., & Ariza, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10030724 · Cited by 148
“If AS degradation depends on the UPS or ALP remains unknown, but both seem to be involved in this process [103].”
BackgroundZhang, M., Deng, Y., Zhang, J., Liu, J., Li, Y., Su, H., & Qu, Q. (2018) · Aging and Disease · doi:10.14336/ad.2017.0517 · Cited by 136
“The autophagy pathway was reported to be relevant to α-synuclein clearance [8].”
BackgroundDual Role of Autophagy in Diseases of the Central Nervous System
Bar-Yosef, T., Damri, O., & Agam, G. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00196 · Cited by 125
“It has been shown that autophagy plays a role in the degradation of the α-synuclein mutants (Webb et al., 2003).”
BackgroundLoss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice
Sato, S., Uchihara, T., Fukuda, T., Noda, S., Kondo, H., Saiki, S., Komatsu, M., Uchiyama, Y., Tanaka, K., & Hattori, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-21325-w · Cited by 125
Leucine regulates autophagy via acetylation of the mTORC1 component raptor
Son, S. M., Park, S. J., Stamatakou, E., Vicinanza, M., Menzies, F. M., & Rubinsztein, D. C. (2020) · Nature Communications · doi:10.1038/s41467-020-16886-2 · Cited by 120
Self-citationAutophagy: links with the proteasome
Lamark, T., & Johansen, T. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.11.002 · Cited by 133
Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity
Menzies, F. M., Garcia-Arencibia, M., Imarisio, S., O'Sullivan, N. C., Ricketts, T., Kent, B. A., Rao, M. V., Lam, W., Green-Thompson, Z. W., Nixon, R. A., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.151 · Cited by 117
“Although the mechanism for the protective effect of CAST in these cases has been suggested to be decrease the cleavage of the relevant protein, these proteins have also been demonstrated to be substrates for autophagic clearance.(3,37) This hints that autophagy upregulation could contribute to the protective mechanism…”
BackgroundSelf-citationThe protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro
Dulovic, M., Jovanovic, M., Xilouri, M., Stefanis, L., Harhaji-Trajkovic, L., Kravic-Stevovic, T., Paunovic, V., Ardah, M. T., El-Agnaf, O. M. A., Kostic, V., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.002 · Cited by 122
Laperle, A., Sances, S., Yucer, N., Dardov, V. J., Garcia, V. J., Ho, R., Fulton, A., Jones, M. R., Roxas, K., Avalos, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-019-0739-1 · Cited by 132
Lysosome‐dependent pathways as a unifying theme in Parkinson's disease
Tofaris, G. K. (2012) · Movement Disorders · doi:10.1002/mds.25136 · Cited by 118
LAMP3 inhibits autophagy and contributes to cell death by lysosomal membrane permeabilization
Tanaka, T., Warner, B. M., Michael, D. G., Nakamura, H., Odani, T., Yin, H., Atsumi, T., Noguchi, M., & Chiorini, J. A. (2021) · Autophagy · doi:10.1080/15548627.2021.1995150 · Cited by 127
Marambio, P., Toro, B., Sanhueza, C., Troncoso, R., Parra, V., Verdejo, H., García, L., Quiroga, C., Munafo, D., Díaz-Elizondo, J., et al. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.02.002 · Cited by 121
“Cytoplasmic inclusion bodies associated with neurodegenerative protein aggregates have shown to be susceptible to macroautophagic degradation [4,11,13,35,36].”
BackgroundNagatsu, T., & Sawada, M. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9061-9 · Cited by 141
“Alpha-synuclein is degraded by both the ubiquitin–protesome pathway and the autophagy–lysosome pathway (Webb et al., 2003).”
BackgroundProtein Misfolding and Aggregation in Parkinson's Disease
Tan, J. M. M., Wong, E. S. P., & Lim, K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2490 · Cited by 139
Garelick, M. G., & Kennedy, B. K. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.030 · Cited by 121
“Alpha synuclein can be degraded by the ubiquitin proteosome pathway and by autophapgy (Webb et al., 2003).”
BackgroundLopez, A., Lee, S. E., Wojta, K., Ramos, E. M., Klein, E., Chen, J., Boxer, A. L., Gorno-Tempini, M. L., Geschwind, D. H., Schlotawa, L., et al. (2017) · Brain · doi:10.1093/brain/awx005 · Cited by 120
“Proteasome substrates also include alpha-synuclein (Webb et al., 2003) and TDP-43 (Huang et al., 2014).”
BackgroundSelf-citationProtein quality control and degradation in cardiomyocytes
Wang, X., Su, H., & Ranek, M. J. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.03.025 · Cited by 131
“The clearance is delayed by either autophagy inhibitors [106,107] or the knockdown of Atg genes [108], whereas induction of autophagy enhances the clearance [106,107].”
Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation
Bae, E.-J., Yang, N. Y., Lee, C.-S., Lee, H.-J., Kim, S., Sardi, S. P., & Lee, S. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.128 · Cited by 135
Fighting disease by selective autophagy of aggregate‐prone proteins
Knævelsrud, H., & Simonsen, A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.041 · Cited by 113
“The major protein constituent of these Lewy bodies is asynuclein, which can be degraded by the proteasome, macroautophagy and CMA [108,109].”
BackgroundInfluentialGao, J., Perera, G., Bhadbhade, M., Halliday, G. M., & Dzamko, N. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008733 · Cited by 113
Novel therapeutic strategies for the treatment of protein-misfolding diseases
Rochet, J.-C. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000385 · Cited by 118
Selective Autophagy: Talking with the UPS
Park, C., & Cuervo, A. M. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9623-7 · Cited by 112
“to degradation by the two above-mentioned systems [92].”
BackgroundAutophagosome dynamics in neurodegeneration at a glance
Wong, Y. C., & Holzbaur, E. L. F. (2015) · Journal of Cell Science · doi:10.1242/jcs.161216 · Cited by 119
“Autophagy can also regulate the turnover of other disease-associated proteins, including amyloid-b (Parr et al., 2012), wild-type a-synuclein (Webb et al., 2003) and transactive response DNA binding protein 43 kDa (TDP-43) (Scotter et al., 2014).”
BackgroundInfluentialmTOR Signaling in Parkinson’s Disease
Lan, A., Chen, J., Zhao, Y., Chai, Z., & Hu, Y. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8417-7 · Cited by 127
DNAJC5 facilitates USP19-dependent unconventional secretion of misfolded cytosolic proteins
Xu, Y., Cui, L., Dibello, A., Wang, L., Lee, J., Saidi, L., Lee, J.-G., & Ye, Y. (2018) · Cell Discovery · doi:10.1038/s41421-018-0012-7 · Cited by 113
Wooten, M. W., Hu, X., Babu, J. R., Seibenhener, M. L., Geetha, T., Paine, M. G., & Wooten, M. C. (2006) · BioMed Research International · doi:10.1155/jbb/2006/62079 · Cited by 113
The alpha-synuclein mutation E46K promotes aggregation in cultured cells
Pandey, N., Schmidt, R. E., & Galvin, J. E. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.019 · Cited by 136
Gao, H., Yang, W., Qi, Z., Lu, L., Duan, C., Zhao, C., & Yang, H. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.06.034 · Cited by 121
Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease
Oji, Y., Hatano, T., Ueno, S.-I., Funayama, M., Ishikawa, K.-I., Okuzumi, A., Noda, S., Sato, S., Satake, W., Toda, T., et al. (2020) · Brain · doi:10.1093/brain/awaa064 · Cited by 116
The Proteasome Inhibition Model of Parkinson’s Disease
Bentea, E., Verbruggen, L., & Massie, A. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160921 · Cited by 125
Parkinson’s disease: experimental models and reality
Jiang, P., & Dickson, D. W. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1788-5 · Cited by 111
“Since the UPS is a major route for αS degradation [208], it is conceivable that the blockage of this pathway could contribute to accumulation of αS and eventual Lewy-related pathology.”
The Vicious Cycle Between α ‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction
Bellomo, G., Paciotti, S., Gatticchi, L., & Parnetti, L. (2019) · Movement Disorders · doi:10.1002/mds.27895 · Cited by 127
“accumulation of α-syn aggregates.(44,75) Similarly, inhibition of macroautophagy by 3-methyladenine led to an increase of both endogenous and overexpressed wildtype (WT) α-syn in PC12 cells.”
BackgroundMichalska, P., & Leon, R. M. (2020) · Antioxidants · doi:10.3390/antiox9080740 · Cited by 119
α-Synuclein pathology as a target in neurodegenerative diseases
Park, H.-J., Kam, T., Dawson, V. L., & Dawson, T. M. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01043-w · Cited by 125
“Degradation of α-synuclein occurs via the ubiquitin–proteasome system and the autophagy–lysosome pathway 224 ; the ubiquitin–proteasome sys-tem seems to be the main degradation pathway for non-pathological α-synuclein, whereas the autophagy–lysosome pathway seems to be the major pathway of…”
α-Synuclein Protofibrils Inhibit 26 S Proteasome-mediated Protein Degradation
Zhang, N.-Y., Tang, Z., & Liu, C.-W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710560200 · Cited by 114
Suppression of autophagy precipitates neuronal cell death following low doses of methamphetamine
Castino, R., Lazzeri, G., Lenzi, P., Bellio, N., Follo, C., Ferrucci, M., Fornai, F., & Isidoro, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05488.x · Cited by 115
The Interplay between Alpha-Synuclein Clearance and Spreading
Lopes da Fonseca, T., Villar-Piqué, A., & Outeiro, T. (2015) · Biomolecules · doi:10.3390/biom5020435 · Cited by 109
“Another line of evidence indicates that macroautophagy inhibitors affect exclusively mutant A53T -syn, while other studies describe different behaviors that vary according to the selected inhibitor [102,145].”
BackgroundConverging Pathways in the Occurrence of Endoplasmic Reticulum (ER) Stress in Huntingtons Disease
Vidal, R., Caballero, B., Couve, A., & Hetz, C. (2011) · Current Molecular Medicine · doi:10.2174/156652411794474419 · Cited by 115
“Increasing evidence indicates that mutant Htt aggregates have a high dependency on autophagy for their clearance, while wild-type species do not rely on autophagy for their degradation [161], and different pharmacological manipulations to enhance autophagy increases the clearance of Htt aggregates and delays the progr…”
BackgroundEmerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk
Paudel, Y. N., Angelopoulou, E., Piperi, C., Shaikh, M. F., & Othman, I. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104593 · Cited by 116
Deneubourg, C., Ramm, M., Smith, L. J., Baron, O., Singh, K., Byrne, S., Duchen, M. R., Gautel, M., Eskelinen, E., Fanto, M., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1943177 · Cited by 120
Intracellular pathways underlying the effects of lithium
Pasquali, L., Busceti, C. L., Fulceri, F., Paparelli, A., & Fornai, F. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833da5da · Cited by 112
“Although initial reports considered asynuclein as a pure substrate of the proteasome, recent findings show that soluble forms of a-synuclein are preferentially degraded by autophagy (Webb et al., 2003).”
BackgroundHirota, Y., & Tanaka, Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0080-9 · Cited by 134
“Although many proteins that cause proteinopathies are partly dependent on the ubiquitin-proteasome pathway for their clearance [62, 63 ], treatment with inhibitors of the autophagy-lysosome pathway or genetic interference that perturbs this pathway also causes the accumulation of aggregated-prone proteins [64–69].”
BackgroundMallory–Denk-bodies: Lessons from keratin-containing hepatic inclusion bodies
Strnad, P., Zatloukal, K., Stumptner, C., Kulaksiz, H., & Denk, H. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.008 · Cited by 131
Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation
Martínez‐Vicente, M. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.03.005 · Cited by 123
Therapeutic Effects of Rapamycin on MPTP-Induced Parkinsonism in Mice
Liu, K., Shi, N., Sun, Y., Zhang, T., & Sun, X. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0909-8 · Cited by 118
“The autophagy-related LC3 protein, an autophagosome marker [6, 24], has previously been detected in dopaminergic neurons of the substantia nigra in mouse models of PD [25].”
BackgroundGenetic Insights into Sporadic Parkinson's Disease Pathogenesis
Chai, C., & Lim, K. (2014) · Current Genomics · doi:10.2174/1389202914666131210195808 · Cited by 135
Cortes, C. J., Qin, K., Cook, J., Solanki, A., & Mastrianni, J. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6189-11.2012 · Cited by 108
“…several neurodegenerative diseases that result from accumulation of misfolded aggregate-prone cytosolic proteins, including Parkinson’s disease (PD) (Webb et al., 2003), amyotrophic lateral sclerosis (Fornai et al., 2008), Huntington’s disease (HD) (Berger et al., 2006), spinocerebellar ataxia…”
BackgroundPenke, B., Bogár, F., Crul, T., Sántha, M., Tóth, M. E., & Vígh, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010325 · Cited by 125
“Autophagy upregulation decreases the toxic accumulation of different mutant proteins such as mutant huntingtin [327] and mutant α-synuclein [328,329].”
BackgroundLv, Q.-K., Tao, K., Wang, X.-B., Yao, X., Pang, M., Liu, J., Wang, F., & Liu, C. (2023) · Inflammation Research · doi:10.1007/s00011-022-01676-x · Cited by 127
“ALP dysfunction contributes to the accumulation of α-syn and loss of dopaminergic neurons in PD [142, 143].”
BackgroundReview: Autophagy in neurodegeneration: firefighter and/or incendiarist?
Rami, A. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01034.x · Cited by 107
Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease
Khalifeh, M., Barreto, G. E., & Sahebkar, A. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14623 · Cited by 114
Evans, J. A., Mendonca, P., & Soliman, K. F. A. (2022) · Nutrients · doi:10.3390/nu14112228 · Cited by 119
Characterization of α‐synuclein aggregation and synergistic toxicity with protein tau in yeast
Zabrocki, P., Pellens, K., Vanhelmont, T., Vandebroek, T., Griffioen, G., Wera, S., LEUVEN, F. V., & Winderickx, J. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04571.x · Cited by 128
Autophagy, Prion Infection and their Mutual Interactions
Heiseke, A., Aguib, Y., & Schatzl, H. M. (2010) · The Prion Protein · doi:10.21775/9781912530076.03 · Cited by 113
The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease
Esteves, A. R., Gozes, I., & Cardoso, S. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.003 · Cited by 120
“ASYN is degraded by both autophagy and proteasome [103].”
BackgroundStress granules at the intersection of autophagy and ALS
Monahan, Z. T., Shewmaker, F. P., & Pandey, U. B. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.022 · Cited by 115
“In the case of both huntingtin and alpha-synuclein, promotion of autophagy via pharmacological stimulation by rapamycin results in an increase in autophagic degradation of the two proteins, as well as a corresponding reduction in toxicity (Ravikumar et al., 2002; Shintani and Klionsky, 2004; Webb et al., 2003).”
BackgroundHu, Q. Z., Uversky, V. N., Huang, M., Kang, H., Xu, F., Liu, X., Lian, L., Liang, Q., Jiang, H., Liu, A., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.008 · Cited by 109
Perfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.569 · Cited by 124
Pathogenic Mechanisms of Neurodegeneration in Parkinson Disease
Mullin, S., & Schapira, A. H. V. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2014.09.010 · Cited by 108
Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice
Ohia-Nwoko, O., Montazari, S., Lau, Y.-S., & Eriksen, J. L. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-54 · Cited by 102
“In addition to aggregated tau, autophagy is also known to promote the degradation of several aggregated proteins associated with neurodegenerative disease, including Aβ [98], huntington [99,100], and alpha-synuclein [100,101].”
BackgroundAlpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
Menon, S. A., Armstrong, S. E. M., Hamzeh, A. M., Visanji, N. P., Sardi, S. P., & Tandon, A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.852003 · Cited by 115
The Multiple Roles of Autophagy in Neural Function and Diseases
Li, Y., Qin, Z., & Sheng, R. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01120-y · Cited by 118
Controlling the mass action of α‐synuclein in Parkinson’s disease
Kim, C., & Lee, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05612.x · Cited by 104
Wilson, C. A., Murphy, D. D., Giasson, B. I., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403061 · Cited by 106
“, 2001), and -synuclein can be degraded by autophagy when overexpressed in PC12 cells (Webb et al., 2003).”
BackgroundWu, A., Wong, V. K. W., Xu, S., Chan, W.-K., Ng, P. C. I., Liu, L., & Law, B. Y. K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122618 · Cited by 113
“A variety of neurodegenerative diseases are caused by toxic, aggregate-prone or oligomeric proteins [5–9].”
BackgroundVekrellis, K., Rideout, H. J., & Stefanis, L. (2004) · Molecular Neurobiology · doi:10.1385/mn:30:1:001 · Cited by 137
“In a more recent study, both proteasomal and lysosomal degradation of α-synuclein were found to occur in inducible cell lines (169).”
Role of Autophagy in Parkinson’s Disease
Cerri, S., & Blandini, F. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180226094351 · Cited by 121
Glutamate, excitotoxicity, and programmed cell death in parkinson disease
Caudle, W. M., & Zhang, J. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.027 · Cited by 127
“In addition to chaperone-mediated autophagy, previous studies have demonstrated a role for macroautophagy in the degradation of wildtype α-synuclein in cell culture models (Vogiatzi et al., 2008; Webb et al., 2003).”
BackgroundAutophagy in ageing and ageing-associated diseases
He, L.-Q., Lu, J.-H., & Yue, Z.-Y. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.188 · Cited by 105
Downregulation of active IKKβ by Ro52-mediated autophagy
Niida, M., Tanaka, M., & Kamitani, T. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.05.004 · Cited by 101
The p75 Neurotrophin Receptor Can Induce Autophagy and Death of Cerebellar Purkinje Neurons
Florez-McClure, M. L., Linseman, D. A., Chu, C. T., Barker, P. A., Bouchard, R. J., Le, S. S., Laessig, T. A., & Heidenreich, K. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5744-03.2004 · Cited by 101
“In contrast, other studies indicate a neuroprotective role for autophagy in Huntington’s disease and -synucleopathies (Qin et al., 2003; Webb et al., 2003).”
Autophagy and polyglutamine diseases
Jimenez-Sanchez, M., Thomson, F., Zavodszky, E., & Rubinsztein, D. C. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.013 · Cited by 103
“Since autophagy substrates can be cleared in cell lines without inclusions visible by light microscopy, this suggests that autophagy can clear monomeric or oligomeric species (Webb et al., 2003) and perhaps the depletion of these leads to an indirect reduction of aggregate number.”
Self-citationDJ‐1 deficiency impairs autophagy and reduces alpha‐synuclein phagocytosis by microglia
Nash, Y., Schmukler, E., Trudler, D., Pinkas‐Kramarski, R., & Frenkel, D. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14222 · Cited by 100
Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications
Balestrino, R., & Schapira, A. H. V. (2018) · The Neuroscientist · doi:10.1177/1073858417748875 · Cited by 95
Pino, E., Amamoto, R., Zheng, L., Cacquevel, M., Sarria, J.-C., Knott, G. W., & Schneider, B. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt530 · Cited by 98
“Alpha-synuclein can be cleared by autophagy and its pathogenic accumulation could be linked to impaired lysosomal autophagic activity (54-56).”
BackgroundTessitore, A., Pirozzi, M., & Auricchio, A. (2009) · PathoGenetics · doi:10.1186/1755-8417-2-4 · Cited by 103
“Alterations in the autophagy-lysosomal degradation pathway have been linked to normal brain aging [39], to agerelated neurodegenerative diseases including Alzheimer's (AD) [40], Parkinson's (PD) [41], and Huntington's (HD) diseases [42] in addition to several LSDs [8-16].”
Backgroundp62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions
Watanabe, Y., Tatebe, H., Taguchi, K., Endo, Y., Tokuda, T., Mizuno, T., Nakagawa, M., & Tanaka, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052868 · Cited by 99
“a-Synuclein is also cleared by these proteolytic systems, supporting the hypothesis that impaired proteasomal and autophagic degradation of a-synuclein is an important mechanism of neurodegeneration in PD [6,7,8,10].”
Background
Metadata
- Authors
- Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C.
- Affiliations
- Addenbrooke's Hospital (GB)
- University of Cambridge (GB)
- Corresponding author
- Rubinsztein, David C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-07
- Volume
- 278
- Issue
- 27
- Pages
- 25009-25013
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2157535220
- Cited by
- 1,429
- References
- 37
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 76 · 2023: 50 · 2022: 68 · 2021: 71 · 2020: 83 · 2019: 85 · 2018: 77 · 2017: 62 · 2016: 65 · 2015: 65 · 2014: 75 · 2013: 79 · 2012: 95
- FWCI
- 18.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6305 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Parkinson's UK
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- alpha-synuclein, Parkinson's disease, autophagy, proteasome, protein degradation, Lewy bodies, A30P mutation, A53T mutation, PC12 cells, rapamycin, autophagic vesicles, dopaminergic neurons
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Autophagy, Cysteine Endopeptidases, Humans, Multienzyme Complexes, Nerve Tissue Proteins, PC12 Cells, Sirolimus, Proteasome Endopeptidase Complex, Rats, Synucleins, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.